Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:EthicsLegal UpdatesLegislation & AdvocacyResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

A Look Back & A Look Ahead: ACR Research and Education Foundation Turns 25

Heather Haley, MS  |  August 1, 2010

The ACR Research and Education Foundation turns 25

What is ICD-9 Coding?

From the College  |  August 1, 2010

The International Classification of Diseases Clinical Modification, 9th Revision (ICD-9 CM) is a list of codes intended for the classification of diseases and a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or disease. The numerical format of the diagnosis codes usually ranges from three to five digits that are assigned to a unique category.

Research Offers Hope of New Therapies to Prevent Bone Loss and Destruction

From the College  |  August 1, 2010

A study recently published in Annals of the Rheumatic Diseases shows promise for potential new therapies to prevent bone loss and bone destruction in patients with rheumatoid arthritis (RA).

Support for Friends of Rheumatology

From the College  |  August 1, 2010

RheumPAC—the voluntary, nonpartisan political action committee of the ACR—works to support and elect pro-rheumatology candidates. RheumPAC representatives were busy in May meeting with supporters of the rheumatology community.

Advocates for Arthritis: My First Time on the Hill

Annelle B. Reed, MSN, CPNP  |  August 1, 2010

When I first read the request for advocates to fly in to Washington D.C., I was intrigued and curious. I’ve heard of visits to Capitol Hill to present important medical issues but was not really sure how the process worked. Politics can seem daunting and complicated, but I know it is necessary to get Congress on board to address medical care. I was excited to be accepted and ready to learn how to best help my patients in the political arena.

What Does Meaningful Use Really Mean?

From the College  |  August 1, 2010

On July 13, the Centers for Medicare and Medicaid Services (CMS) announced the publication of the final rule for the electronic health record (EHR) incentive program. The final rule announcement ended the holding pattern for providers eager to make the switch from paper to digital medical records.

Our Commitment to Research

Stanley B. Cohen, MD  |  August 1, 2010

The ACR has a wide range of programs to support investigations in rheumatology

REF Investigators’ Meeting Brings Researchers Together to Search for RA Cure

Charlotte Huff  |  August 1, 2010

REF Investigators’ Meeting brings researchers together to search for RA cure

The Basic Science of the Annual Scientific Meeting

From the College  |  July 1, 2010

The ACR/ARHP Annual Scientific Meeting is the premier event for specialists in the field of rheumatology. At this year’s meeting, basic researchers will have multiple opportunities to increase their knowledge, and there will be something for every interest.

Within Our Reach: Collaborating to Find a Cure for RA

David R. Karp, MD, PhD  |  July 1, 2010

Research is critically important to find cures and accelerate patient care for the millions who suffer from arthritis and rheumatic disease. Despite its prevalence in the population and recent treatment advances, rheumatoid arthritis (RA) remains an incurable disease and receives disproportionately less research funding from federal sources than most other autoimmune diseases. This is precisely why the ACR Research and Education Foundation (REF) launched Within Our Reach: Finding a Cure for Rheumatoid Arthritis to directly invest in the types of innovative research not being done elsewhere in the country.

  • « Previous Page
  • 1
  • …
  • 220
  • 221
  • 222
  • 223
  • 224
  • …
  • 248
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences